Feedback / Questions
177Lu-SN201 - Spago Nanomedical
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/spago-nanomedical-proceeds-with-increased-dose-in-the-phase-iiia-study-995400
Mar 4, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next